TTR and neoplasm: Kaplan–Meier analysis and the log-rank test showed that patients with negative CAPS1 expression in tumor tissues had a significantly shorter median OS and TTR (OS, 30.8 months; TTR, 18.3 months) than those with positive CAPS1 expression (OS, 53.4 months, p = 0.008; TTR, 32.6 months, p = 0.015) (Figure 2A,B).